Cancer Type: Leukaemia

Search News
Categories
Archives
Dr Diu Nguyen

6th April 2022

The overarching goal of our laboratory is to understand the biology of normal haematopoietic and leukaemic stem cells in order to selectively kill cancer stem cells for better leukaemia treatment.

Read more

Dr Ana Levi

5th May 2021

My focus is on investigating the epigenetic regulation of the PI3K pathway and identifying an effective combination therapy that will disable compensatory bypass routes, overcoming drug resistance.

Read more

Dr Christopher Mapperley

22nd April 2021

My research is focused on investigating how the epitranscriptome regulates normal and malignant haematopoiesis.

Read more

Dr Miguel Ganuza

6th February 2020

Our goal is to identify mechanisms that support haematopoietic stem cell function and understand how the leukaemic stem cells “play” with these mechanisms to thrive.

Read more

Dr Paolo Gallipoli

17th September 2019

My research interests focus on mechanisms of disease initiation and maintenance and the identification and validation of novel therapeutic targets in myeloid leukaemias.

Read more

Dr Marta Crespi-Sallan

20th December 2018

My research is focused on describing the mechanisms underlying Lamin B1 nuclear disassembly in B-cell normal development and how a dis-regulated Lamin B1 removal pathway could lead to several haematological malignancies within the germinal centre in secondary lymph organs.

Read more

Search News
Categories
Archives